文献速递慢性静脉疾病静脉血栓栓塞

200例专用静脉支架治疗患者的通畅率与临床结局队列研究

Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-02-13

本研究分析了在一家三级大学转诊中心接受sinus-Venous专用静脉支架治疗的200例患者,其中经皮手术103例(51%)为血栓后综合征(PTS),48例(24%)为髂静脉压迫综合征(IVCS),49例(25%)为杂交手术。中位随访12(11-12)个月,总体一期通畅率68%、辅助一期通畅率83%、二期通畅率90%;Villalta评分从10.5±4.2降至5.3±3.8(P<.001),静脉性跛行132例中115例(87%)消退。结论认为短期临床结果与既往研究相当,支架相关扭结或 tapered 导致的通畅丧失在此短期随访中几乎未见。

要点

  • 200例接受sinus-Venous专用静脉支架治疗,PTS占51%、IVCS占24%、杂交手术占25%。
  • 中位随访12个月,一期、辅助一期、二期通畅率分别为68%、83%、90%。
  • Villalta评分从10.5±4.2降至5.3±3.8(P<.001),静脉性跛行132例中115例(87%)消退。

核心结论

  • 使用sinus-Venous支架的短期临床结果与既往研究相当,支架相关扭结或 tapered 导致的通畅丧失在此短期随访中几乎未见。

研究设计与样本

  • 研究为队列分析,纳入在一家三级大学转诊中心接受治疗的200例患者。
  • 经皮手术103例(51%)为PTS,48例(24%)为IVCS;49例(25%)行杂交手术。
  • 通过双功超声分析通畅率与并发症,采用Venous Clinical Severity Score、Villalta量表及静脉性跛行率评估临床改善。

主要发现

  • 平均年龄43.2±14.5(17-81)岁,女性占66%。
  • 平均Villalta评分从10.5±4.2(3-24)降至末次随访时5.3±3.8(0-14)(P<.001)。
  • Venous Clinical Severity Score总共降低3分(P<.001)。
  • 基线时静脉性跛行见于132例患者,其中115例(87%)消退。
  • 中位随访12(11-12)个月,总体一期通畅率68%、辅助一期通畅率83%、二期通畅率90%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Minimally invasive interventions by recanalization, percutaneous transluminal angioplasty, and stenting in post-thrombotic syndrome (PTS) obstructions and iliac vein compression syndrome (IVCS) have shown good results. Until recently, no dedicated venous stents were available, and stent-related issues accounted for a decrease in patency scores. The introduction of dedicated stents with more flexibility and higher radial forces could result in higher patency scores. This study focused on the outcomes of patients treated by a dedicated sinus-Venous stent (OptiMed GmbH, Ettlingen, Germany). Patency rates and clinical evaluation are described for both PTS and IVCS patients. METHODS: A total of 200 patients treated at a tertiary university referral center were analyzed. A percutaneous procedure was performed in 103 (51%) PTS patients and 48 (24%) IVCS patients. In 49 (25%) patients, a hybrid procedure was executed. Patency rates and complications were analyzed by duplex ultrasound. Clinical improvement was scored by Venous Clinical Severity Score, Villalta scale, and venous claudication rates. RESULTS: The mean age was 43.2 ± 14.5 (17-81) years, and 66% were female. Mean Villalta score decreased from 10.5 ± 4.2 (3-24) to 5.3 ± 3.8 (0-14) at the latest follow-up (P < .001). Venous Clinical Severity Score decreased by a total of 3 points (P < .001). At baseline, venous claudication was present in 132 patients, which subsided in 115 (87%). Overall patency scores revealed a primary patency of 68%, assisted primary patency of 83%, and secondary patency of 90% with a median follow-up of 12 (11-12) months. Of all included patients, 122 (61%) did not have a complication during follow-up; the most frequent complications were in-stent restenosis (n = 23) and occlusion (n = 25) of the stented tract. CONCLUSIONS: Short-term clinical results using the sinus-Venous stent are comparable to previous research. Loss of stent patency due to stent-related issues like kinking or tapering is hardly ever seen in this short-term follow-up.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. van Vuuren TMAJ, Doganci S, Wittens CHA, et al. Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29396156. doi:10.1016/j.jvsv.2017.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。